The World Patient Safety Congress Americas is the premier global marketplace for C-suite executives, R&D specialists, and data leaders to define the future of pharmacovigilance and patient safety.
Key 2026 Event Details
The 2026 edition will take place from October 13ā€“15, 2026, at the Thomas M. Menino Convention and Exhibition Center in Boston, Massachusetts. The event runs for three days, with pre-congress workshops on October 13 followed by the main congress on October 14-15.
Event Scale and Attendees
The congress is expected to bring together over 1,200 to 1,800 leaders from pharma, biotech, and regulatory bodies. The event features more than 250 speakers across 10 content tracks, with 100+ exhibitors showcasing innovative products and solutions.
Key Themes and Topics
The congress explores the intersection of drug safety strategy and technological disruption. Major focus areas include:
- AI, automation, and Real-World Evidence (RWE)Ā in safety monitoring and risk management
- Benefit-risk managementĀ and patient-centric approaches
- Signal management, quality assurance, outsourcing, and regulatory compliance
- Safety across all regulated product categories, from pharmaceutical drugs and medical devices to cosmetics and dietary supplements
Notable Speakers
The 2026 speaker lineup includes senior leaders from major pharmaceutical and biotech organizations:
| Speaker | Organization |
|---|---|
| Felix Arellano | Roche |
| Mariette Boerstoel | Bristol Myers Squibb |
| Tanmay Desai | Kyowa Kirin |
| Karthik Muthusamy | Novo Nordisk |
| Julie Thomas | Johnson & Johnson |
| Juhaeri Juhaeri | Sanofi |
| Aysha Amman | Amneal Pharmaceuticals |
| Peter Hjelmstrom | Uppsala Monitoring Centre |
| Israel Gutierrez | TLR Therapeutics |
| Anuj Parikh, MD | Jazz Pharmaceuticals |
| Dana Singer, MD | Jazz Pharmaceuticals |
| Viny Srinivasan | Unilever |
Peter Hjelmstrƶm, Director/CEO of Uppsala Monitoring Centre, has described the congress as “one of the best meetings in the PV space gathering both scientific, industrial and regulatory thought leaders.”
Networking and Exhibition
Networking is a central component of the event, with built-in one-on-one networking opportunities connecting attendees with thousands of thought leaders across two days. The exhibition floor allows attendees to discover innovative products and solutions revolutionizing the future of drug safety and patient safety.
Event History
The World Patient Safety Congress Americas was formerly known as the World Drug Safety Congress Americas. It has evolved into a comprehensive gathering that brings together international regulatory bodies, industry professionals, and patient representatives to foster a collaborative culture of innovation that improves safety outcomes across all regulated product categories.
